The estimated Net Worth of Geoffrey Martha is at least $23.8 Миллион dollars as of 2 August 2024. Mr Martha owns over 18,966 units of Medtronic Plc stock worth over $18,348,820 and over the last 10 years he sold MDT stock worth over $1,388,937. In addition, he makes $4,091,565 as Chairman & CEO at Medtronic Plc.
Mr has made over 8 trades of the Medtronic Plc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 18,966 units of MDT stock worth $1,713,578 on 2 August 2024.
The largest trade he's ever made was exercising 49,799 units of Medtronic Plc stock on 24 September 2018 worth over $1,820,153. On average, Mr trades about 4,165 units every 89 days since 2015. As of 2 August 2024 he still owns at least 203,086 units of Medtronic Plc stock.
You can see the complete history of Mr Martha stock trades at the bottom of the page.
Geoffrey Straub Martha is the Chairman & CEO at Medtronic Plc.
As the Chairman & CEO of Medtronic Plc, the total compensation of Mr Martha at Medtronic Plc is $4,091,565. There are no executives at Medtronic Plc getting paid more.
Mr Martha is 51, he's been the Chairman & CEO of Medtronic Plc since . There are 5 older and 1 younger executives at Medtronic Plc. The oldest executive at Medtronic Plc is Bradley E. Lerman, 65, who is the Sr. VP, Gen. Counsel & Corp. Sec..
Geoffrey's mailing address filed with the SEC is 710 MEDTRONIC PARKWAY, , MINNEAPOLIS, MN, 55432.
Over the last 10 years, insiders at Medtronic Plc have traded over $102,147,437 worth of Medtronic Plc stock and bought 88,808 units worth $7,888,497 . The most active insiders traders include Randall J Hogan, Richard H Anderson и Scott C Donnelly. On average, Medtronic Plc executives and independent directors trade stock every 23 days with the average trade being worth of $1,897,982. The most recent stock trade was executed by Brett A. Wall on 2 August 2024, trading 5,311 units of MDT stock currently worth $479,849.
Medtronic plc is an American medical device company. The companys operational and executive headquarters are in Minneapolis, Minnesota, and its legal headquarters are in Ireland due to its acquisition of Irish-based Covidien in 2015.
Medtronic Plc executives and other stock owners filed with the SEC include: